PPA
MDGL icon

Parametric Portfolio Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History

Parametric Portfolio Associates’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.09M Sell
11,136
-7,480
-40% -$631K ﹤0.01% 2739
2021
Q4 		$1.58M Sell
18,616
-8
-0% -$657 ﹤0.01% 2588
2021
Q3 		$1.49M Buy
18,624
+11,659
+167% +$1.01M ﹤0.01% 2607
2021
Q2 		$678K Sell
6,965
-392
-5% -$46.4K ﹤0.01% 2953
2021
Q1 		$861K Buy
7,357
+4,139
+129% +$483K ﹤0.01% 3233
2020
Q4 		$358K Buy
3,218
+959
+42% +$117K ﹤0.01% 3528
2020
Q3 		$268K Buy
2,259
+168
+8% +$18.2K ﹤0.01% 3535
2020
Q2 		$237K Buy
+2,091
New +$206K ﹤0.01% 3567
2018
Q4 		– Sell
-4,560
Closed -$976K – 3938
2018
Q3 		$976K Sell
4,560
-6,627
-59% -$1.66M ﹤0.01% 3113
2018
Q2 		$3.13M Sell
11,187
-3,236
-22% -$568K ﹤0.01% 2341
2018
Q1 		$1.68M Sell
14,423
-849
-6% -$105K ﹤0.01% 2730
2017
Q4 		$1.4M Buy
+15,272
New +$872K ﹤0.01% 2835
2015
Q4 		– Sell
-500
Closed -$30K – 3972
2015
Q3 		$30K Buy
500
+146
+41% +$10.5K ﹤0.01% 3251
2015
Q2 		$28K Buy
+354
New +$29.7K ﹤0.01% 3942
2015
Q1 		– Sell
-461
Closed -$43K – 3977
2014
Q4 		$43K Buy
461
+70
+18% +$7.24K ﹤0.01% 3953
2014
Q3 		$41K Buy
+391
New +$54.4K ﹤0.01% 3780
2014
Q2 		– Sell
-741
Closed -$112K – 3767
2014
Q1 		$112K Buy
741
+386
+109% +$76K ﹤0.01% 3733
2013
Q4 		$65K Buy
355
+54
+18% +$9.89K ﹤0.01% 3762
2013
Q3 		$67K Buy
301
+5
+2% +$1.06K ﹤0.01% 3750
2013
Q2 		$52K Buy
+296
New +$77.2K ﹤0.01% 3656

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Parametric Portfolio Associates's MDGL Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Madrigal Pharmaceuticals (MDGL) stake by 40% in Q1 2022, selling an estimated $631K and leaving 11,136 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

Parametric Portfolio Associates first reported a position in MDGL in Q2 2013 and has held it in 20 quarters since. The position peaked at $3.13M in Q2 2018. 140 funds tracked by Wall St. Rank hold MDGL as of Q1 2022.

  • Parametric Portfolio Associates held 11,136 shares of Madrigal Pharmaceuticals worth $1.09M as of Q1 2022.
  • Parametric Portfolio Associates sold 7,480 Madrigal Pharmaceuticals shares in Q1 2022, an estimated $631K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2739 holding.
  • Parametric Portfolio Associates first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • Parametric Portfolio Associates's Madrigal Pharmaceuticals position peaked at $3.13M in Q2 2018.
  • 140 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.